Arvinas to Participate in Upcoming Investor Conferences
(NASDAQ:ARVN) NEW HAVEN, Conn., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degr...
3 days ago